📰 Global Clinical Sciences News
Global Clinical Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Global Clinical Sciences. Real-time updates on events, politics, business and more.
February 20, 2022
Three physicians with the FDA are suggesting that it might be time to give drug companies a deadline to meet accelerated approval requirements, as is done in other countries.
January 29, 2021
Share this article Share this article BEIJING and BRIDGEWATER, N.J., Jan. 29, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for GLR2007, for the treatment of patients with glioblastoma. GLR2007 is a cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor that Gan & Lee is developing for the treatm...
January 29, 2021
29 gennaio 2021 15:38 Fonte: Adnkronos #salute-e-benessere BEIJING and BRIDGEWATER, N.J., Jan. 29, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for GLR2007, for the treatment of patients with glioblastoma. GLR2007 is a cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor that Gan & Lee is dev...